Adicet Bio
ACET
ACET
107 hedge funds and large institutions have $231M invested in Adicet Bio in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
37% less capital invested
Capital invested by funds: $370M → $231M (-$138M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
107
Holding in Top 10
1
Calls
$1.1M
Puts
$186K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$11.1M | |
| 3 | +$1.65M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.19M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$953K |
Top Sellers
| 1 | -$9.91M | |
| 2 | -$5.36M | |
| 3 | -$3.75M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.24M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.74M |